home / stock / pbla / pbla news

PBLA News and Press, Panbela Therapeutics Inc Com From 09/05/23

Stock Information
Company Name: Panbela Therapeutics Inc Com
Stock Symbol: PBLA
Market: NASDAQ
Website: panbela.com
Menu
PBLA PBLA Quote PBLA Short PBLA News PBLA Articles PBLA Message Board
Get PBLA Alerts

News, Short Squeeze, Breakout and More Instantly...
PBLA - Panbela Announces Issuance of New Patent in Chile for Claims of a Novel Process for the Production of Flynpovi

MINNEAPOLIS, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced an Issue Notification for the Chilean patent 11...
PBLA - Panbela to Present at H.C. Wainwright 25th Annual Global Investment Conference

MINNEAPOLIS, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, announced that management will be presenting virtually at the H....

PBLA - Panbela Announces Issuance of New Patent in Europe for Claims of a Novel Process for the Production of SBP-101

MINNEAPOLIS, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced an Issue Notification for the European patent 20...

PBLA - Panbela Therapeutics, Inc. (PBLA) Q2 2023 Earnings Call Transcript

2023-08-10 22:42:07 ET Panbela Therapeutics, Inc. (PBLA) Q2 2023 Earnings Conference Call August 10, 2023 16:30 ET Company Participants James Carbonara - Investor Relations Jennifer Simpson - Chief Executive Officer Sue Horvath - Chief Financial Officer Con...
PBLA - Panbela Therapeutics GAAP EPS of -$7.95 misses by $3.24

2023-08-10 16:21:54 ET Panbela Therapeutics press release ( NASDAQ: PBLA ): Q2 GAAP EPS of -$7.95 misses by $3.24 . Total cash was $7.2 million as of June 30, 2023. For further details see: Panbela Therapeutics GAAP EPS of -$7.95 misses by $3.24

PBLA - Panbela Provides Business Update and Reports Q2 2023 Financial Results

MINNEAPOLIS , Aug. 10, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today provides a business update and reports financial results for the qua...

PBLA - Panbela to Host Second Quarter 2023 Earnings Conference Call on August 10, 2023

MINNEAPOLIS, July 31, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced that it will host a conference call on August 10, 2023, ...
PBLA - Panbela Opens Enrollment in UK and Germany for Aspire Trial in Pancreatic Cancer, All Countries/Regions in the Aspire Trial are Now Open and Actively Enrolling

MINNEAPOLIS, July 24, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc . (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced it has opened enrollment in the UK and Germany for its ASPIRE glo...

PBLA - FYBR, NVNO and PBLA among mid-day movers

2023-07-19 13:19:29 ET Gainers: SMX Public Limited Company ( SMX ) +37% . Marti Technologies ( MRT ) +31% . Carvana ( CVNA ) +29% . 60 Degrees Pharmaceuticals ( SXTP ) +27% . Wheels Up Experience ( UP ) +26% . enVVeno Medical...

PBLA - Panbela, 60 Degrees top healthcare gainers; Amarin, Aptevo among losers

2023-07-19 10:22:17 ET Gainers: Panbela Therapeutics ( PBLA ) +36% . 60 Degrees Pharmaceuticals ( SXTP ) +20% . CareMax ( CMAX ) +20% . Biodexa Pharmaceuticals ( BDRX ) +13% . bluebird bio ( BLUE ) +13% . Losers: Amar...
Previous 10 Next 10